Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,568.71
    -619.81 (-0.97%)
     

  • CMC Crypto 200

    1,320.64
    -75.89 (-5.42%)
     

  • S&P 500

    5,103.78
    +55.36 (+1.10%)
     

  • Dow

    38,255.79
    +169.99 (+0.45%)
     

  • Nasdaq

    15,931.72
    +319.96 (+2.05%)
     

  • Gold

    2,349.50
    +7.00 (+0.30%)
     

  • Crude Oil

    84.06
    +0.49 (+0.59%)
     

  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Paratek: 3Q Earnings Snapshot

Paratek: 3Q Earnings Snapshot

Associated Press

BOSTON (AP) _ Paratek Pharmaceuticals Inc. (PRTK) on Tuesday reported a loss of $32.1 million in its third quarter.

The Boston-based company said it had a loss of $1.01 per share.

The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.

The pharmaceutical company posted revenue of $50,000 in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $5.9 million.

Paratek shares have fallen 61 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.98, a decline of 69 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTK at https://www.zacks.com/ap/PRTK